Findings from a phase 1 trial show that a single dose of an experimental therapy produced greater than 94% reductions in blood levels of lipoprotein(a), a key driver of heart disease risk, with the results lasting for nearly a year
Reviving History: 450-Million-Year-Old Organism Finds New Life in Softbotics
Satellite data and 100-year-old images reveal quickening retreat of Greenland's glaciers